Q2 FY2026 · ended Jun 30, 2026 · Revenue $1.92M, +13.1% YoY · Filed Aug 13, 2026
BIO-key International, Inc. (BKYI) files with the SEC under industry code 7372, Services-Prepackaged Software. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $1.9 million and a net loss of $576,852. Free cash flow was -$845,749. As of Jun 30, 2026 it held $1.4 million in cash and investments and $149,732 in total debt.
Revenue
$1.92M
+13.1% vs year-ago quarter
Net income
$-576,852
+50.6% vs year-ago quarter
Operating cash flow
$-845,749
+3.9% vs year-ago quarter
Free cash flow
$-845,749
+4.1% vs year-ago quarter
EPS
—
Dividend per share
None
Shares outstanding
1.44M
-79.1% vs year-ago quarter
Net cash
$1.23M
Q2 FY2026
Operating margin
-86.4%
TTM
Company profile
- Industry
- Services-Prepackaged Software (SIC 7372)
- Listed as
- BKYI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Holmdel, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1019034
- Former names
- SAC TECHNOLOGIES INC (until Jan 17, 2002)
Other Services-Prepackaged Software companies
- Microsoft Corp MSFT
- Palantir Technologies Inc. PLTR
- Oracle Corp ORCL
- Sap SE SAP
- CrowdStrike Holdings, Inc. CRWD
- Shopify Inc. SHOP
- Salesforce, Inc. CRM
- ServiceNow, Inc. NOW
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $1.9M | $2.1M | $1.1M | $1.5M | $1.7M |
| Operating income | -$529,405 | -$157,713 | -$4.2M | -$892,190 | -$1.1M |
| Net income | -$576,852 | -$205,037 | -$4.3M | -$964,849 | -$1.2M |
| Operating cash flow | -$845,749 | -$358,001 | -$1.8M | -$1.1M | -$880,012 |
| Free cash flow | -$845,749 | -$358,001 | -$1.8M | -$1.1M | -$881,490 |
| Total assets | $7.5M | $8.2M | $8.3M | $10.1M | $10.5M |
| Total liabilities | $3.1M | $3.3M | $3.2M | $4.1M | $3.7M |
| Stockholders' equity | $4.3M | $4.9M | $5.1M | $6.0M | $6.9M |
| Cash and investments | $1.4M | $2.2M | $2.7M | $7.0M | $7.3M |
| Total debt | $149,732 | $42,409 | $48,994 | $54,433 | $60,829 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Shareholder vote results
|
Oct 30, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Oct 6, 2026 | Oct 2, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 2, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Other events
|
Sep 8, 2026 | Sep 3, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 13, 2026 | Aug 10, 2026 |
All 1000 BIO-key International, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.